A Study of Mirikizumab in Participants With Plaque Psoriasis
Clinical trial NCT03718884 · COMPLETED
Trial details
- NCT number
- NCT03718884
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-23
- Primary completion
- 2019-10-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.